Related Experiment Video
Updated: Jan 26, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
MicroRNA-331-3p inhibits epithelial-mesenchymal transition by targeting ErbB2 and VAV2 through the
Xizhe Li1, Jiali Zhu2, Yuanqi Liu1
1Department of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha, China.
Abstract:
MicroRNAs have been reported to play critical roles in the regulation of non-small-cell cancer (NSCLC) development, but the role of microRNA (miR)-331-3p in NSCLC is still unclear. In this study, the expression levels of miR-331-3p in NSCLC tumor tissues and adjacent normal tissues were examined by quantitative RT-PCR, and the relationship between miR-331-3p expression and patient clinicopathological characteristics was analyzed. The effects of miR-331-3p on epithelial-mesenchymal transition (EMT), migration, and metastasis of NSCLC cells were determined in vitro and vivo. Direct functional targets of miR-331-3p were identified by luciferase reporter assay, western blot assay, immunohistochemical staining, and rescue assay. The downstream pathway regulated by miR-331-3p was identified by immunofluorescence, immunoprecipitation, and Rac1 activity examination. Our results showed that miR-331-3p was significantly downregulated in NSCLC tumor tissues and was correlated with clinicopathological characteristics, and miR-331-3p could be an independent prognostic marker for NSCLC patients. Furthermore, miR-331-3p significantly suppressed EMT, migration and metastasis of NSCLC cells in vitro and in vivo. Both ErbB2 and VAV2 were direct functional targets of miR-331-3p. The activities of Rac1, PAK1, and β-catenin were regulated by miR-331-3p through ErbB2 and VAV2 targeting. These results indicated that miR-331-3p suppresses EMT, migratory capacity, and metastatic ability by targeting ErbB2 and VAV2 through the Rac1/PAK1/β-catenin axis in NSCLC.
Insights
MicroRNA-331-3p is downregulated in non-small-cell lung cancer (NSCLC), suppressing tumor cell migration and metastasis. This microRNA targets ErbB2 and VAV2, impacting the Rac1/PAK1/β-catenin pathway and serving as a prognostic marker for NSCLC patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs regulate non-small-cell lung cancer (NSCLC) development.
- The specific role of microRNA (miR)-331-3p in NSCLC remains largely undetermined.
- Understanding miR-331-3p's function is crucial for identifying novel therapeutic targets and prognostic markers in NSCLC.
Purpose of the Study:
- To investigate the expression levels and clinical significance of miR-331-3p in NSCLC.
- To elucidate the role of miR-331-3p in regulating NSCLC cell epithelial-mesenchymal transition (EMT), migration, and metastasis.
- To identify the direct targets and downstream pathways modulated by miR-331-3p in NSCLC.
Main Methods:
- Quantitative RT-PCR to assess miR-331-3p expression in NSCLC tissues.
- In vitro and in vivo assays to evaluate the effects of miR-331-3p on cell migration and metastasis.
- Luciferase reporter assays, Western blot, and immunohistochemistry to identify direct targets.
- Immunofluorescence, immunoprecipitation, and Rac1 activity assays to determine the downstream pathway.
Main Results:
- miR-331-3p was significantly downregulated in NSCLC tissues and correlated with clinicopathological characteristics.
- Downregulation of miR-331-3p was associated with poorer prognosis, identifying it as an independent prognostic marker.
- miR-331-3p suppressed EMT, migration, and metastasis of NSCLC cells both in vitro and in vivo.
- ErbB2 and VAV2 were identified as direct targets of miR-331-3p.
- miR-331-3p regulated the activities of Rac1, PAK1, and β-catenin through targeting ErbB2 and VAV2.
Conclusions:
- miR-331-3p acts as a tumor suppressor in NSCLC by inhibiting EMT, migration, and metastasis.
- The tumor-suppressive function of miR-331-3p is mediated through the targeting of ErbB2 and VAV2, subsequently affecting the Rac1/PAK1/β-catenin signaling axis.
- miR-331-3p holds potential as a valuable prognostic biomarker for NSCLC patients.
Related Concept Videos
MicroRNAs
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Phase Transitions
Feedback Inhibition
Properties of Transition Metals

